(Q42114253)

16 October 2017

Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma (English)

1 reference

16 October 2017

0 references

Nakano T

1

1 reference

16 October 2017

Chahinian AP

2

1 reference

16 October 2017

Shinjo M

3

1 reference

16 October 2017

Tonomura A

4

1 reference

16 October 2017

Miyake M

5

1 reference

16 October 2017

Togawa N

6

1 reference

16 October 2017

Ninomiya K

7

1 reference

16 October 2017

Higashino K

8

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Cancer

16 October 2017

1 reference

16 October 2017

77

1 reference

16 October 2017

6

1 reference

16 October 2017

907-912

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.150

16 October 2017

0 references

cites work

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

The role of tumor necrosis factor (cachectin) in cachexia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

A possible autocrine role for interleukin-6 in two lymphoma cell lines.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Thrombocytosis in malignant pleural mesothelioma.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Interleukin-6-Producing Pheochromocytoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

The evidence for interleukin-6 as an autocrine growth factor in malignancy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150109

Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis

29 May 2018

1 reference

12 December 2020

Acute-Phase Proteins and Interleukin 6 Serum Level in Head and Neck Cancer

1 reference

12 December 2020

Potential for Interferon-α-Based Therapy in Mesothelioma: Assessment in a Murine Model

1 reference

12 December 2020

Thrombocytosis in patients with malignant pleural mesothelioma

1 reference

12 December 2020

Serum levels of interleukin-6 and acute phase responses

1 reference

12 December 2020

Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma

1 reference

12 December 2020

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

12 December 2020

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

12 December 2020

Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Interleukin-6 is a potent thrombopoietic factor in vivo in mice

1 reference

12 December 2020

Thrombopoietic activity of human interleukin-6

1 reference

12 December 2020

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.150

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

9528833

1 reference